Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy by Vincenzo Montesarchio, Paolo Antonio Ascierto, Antonio Maria Grimaldi, Marcello Curvietto, Domenico Mallardo, Marco Palla, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna De Rosa, Luigi Atripaldi, Maurizio D’Abbraccio, Egidio Celentano, Claudia Trojaniello, Maria Grazia Vitale, Samuel Lewis Million-Weaver, Roberto Parrella

Get full text